COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries
Top Cited Papers
Open Access
- 1 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Epidemiology
- Vol. 36 (2), 197-211
- https://doi.org/10.1007/s10654-021-00728-6
Abstract
With the development of multiple effective vaccines, reducing the global morbidity and mortality of COVID-19 will depend on the distribution and acceptance of COVID-19 vaccination. Estimates of global vaccine acceptance among pregnant women and mothers of young children are yet unknown. An understanding of the challenges and correlates to vaccine acceptance will aid the acceleration of vaccine administration within these populations. Acceptance of COVID-19 vaccination among pregnant women and mothers of children younger than 18-years-old, as well as potential predictors, were assessed through an online survey, administered by Pregistry between October 28 and November 18, 2020. 17,871 total survey responses from 16 countries were obtained. Given a 90% COVID-19 vaccine efficacy, 52.0% of pregnant women (n = 2747/5282) and 73.4% of non-pregnant women (n = 9214/12,562) indicated an intention to receive the vaccine. 69.2% of women (n = 11,800/17,054), both pregnant and non-pregnant, indicated an intention to vaccinate their children. Vaccine acceptance was generally highest in India, the Philippines, and all sampled countries in Latin America; it was lowest in Russia, the United States and Australia. The strongest predictors of vaccine acceptance included confidence in vaccine safety or effectiveness, worrying about COVID-19, belief in the importance of vaccines to their own country, compliance to mask guidelines, trust of public health agencies/health science, as well as attitudes towards routine vaccines. COVID-19 vaccine acceptance and its predictors among women vary globally. Vaccination campaigns for women and children should be specific for each country in order to attain the largest impact.Keywords
Funding Information
- Human Immunomics Initiative at the Harvard TH Chan School of Public Health
- Pregistry, LLC
This publication has 19 references indexed in Scilit:
- Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–June 7, 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Public Health Agency of Sweden's Brief Report: Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in SwedenActa Obstetricia et Gynecologica Scandinavica, 2020
- Children are unlikely to be the main drivers of the COVID‐19 pandemic – A systematic reviewActa Paediatrica, 2020
- SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic ReviewClinical Infectious Diseases, 2020
- Vaccine confidence in the time of COVID-19European Journal of Epidemiology, 2020
- Lessons learned from engaging communities for Ebola vaccine trials in Sierra Leone: reciprocity, relatability, relationships and respect (the four R’s)BMC Public Health, 2019
- Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccinationInternational Journal of Clinical Oncology, 2014
- Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012Vaccine, 2014
- Vaccine hesitancyHuman Vaccines & Immunotherapeutics, 2013
- Addressing the vaccine confidence gapThe Lancet, 2011